Provided by Tiger Fintech (Singapore) Pte. Ltd.

AEON Biopharma

0.4304
-0.0296-6.43%
Post-market: 0.43990.0095+2.21%19:58 EDT
Volume:215.36K
Turnover:96.79K
Market Cap:4.53M
PE:0.01
High:0.4672
Open:0.4672
Low:0.4302
Close:0.4600
Loading ...

NYSE American Most Active Issues

Dow Jones
·
22 Jan

NYSE American Most Active Issues

Dow Jones
·
17 Jan

AEON Credit Service Announces Change in Share Registrar

TIPRANKS
·
15 Jan

NYSE American Most Active Issues

Dow Jones
·
14 Jan

NYSE American New 52-Week Highs And Lows

Dow Jones
·
13 Jan

AEON Co. Reports Steady Revenue Growth Amid Challenges

TIPRANKS
·
11 Jan

AEON Mall's Attributable Profit Drops Nearly 17% in Fiscal Q3

MT Newswires Live
·
10 Jan

AEON Co. Reports Revenue Growth but Faces Profitability Challenges

TIPRANKS
·
10 Jan

AEON Delight Co. Reports Rising Profits and Steady Growth

TIPRANKS
·
09 Jan

AEON DELIGHT Announces Share Retirement

TIPRANKS
·
09 Jan

AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering

THOMSON REUTERS
·
07 Jan

AEON Biopharma, Inc. Announces Closing of $20.0 Million Underwritten Public Offering

GlobeNewswire
·
07 Jan

AEON REIT Cancels 21,383 Investment Units Without Impacting Financial Forecasts

TIPRANKS
·
07 Jan

NYSE American Most Active Issues

Dow Jones
·
07 Jan

Aeon Biopharma Shares Fall After Pricing of $20 Million Public Offering

MT Newswires Live
·
06 Jan

NYSE American New 52-Week Highs And Lows

Dow Jones
·
06 Jan

BRIEF-Aeon Biopharma, Inc. Announces Pricing Of Approximately $20.0 Million Underwritten Public Offering

Reuters
·
06 Jan

AEON Biopharma’s $20M Offering for ABP-450 Development

TIPRANKS
·
06 Jan

AEON Biopharma, Inc. Announces Pricing of Approximately $20.0 Million Underwritten Public Offering

THOMSON REUTERS
·
06 Jan

AEON Biopharma Inc - Transaction Expected to Close on January 7, 2025

THOMSON REUTERS
·
06 Jan